In Conversation

Over the next three years, our focus is set on three fundamental elements to drive growth and impact: portfolio transformation, capability building, and expanding the HCP…

Our collective journey to build a leading international dermatology company in India has just begun, and I am confident that with the dedication, passion, and unwavering…

[We must] avoid placing AI at the centre and then working backwards to find a problem. Instead, we should take a problem-centric approach, identifying real-world challenges…

Our aspirations are ambitious, aiming for a three-fold increase in size over the next 8-10 years

We have the experience, the footprint, the governance, and the ambition to leverage the opportunities ahead and forge a new path for pharmaceuticals in Gujarat

The funding landscape for science in Portugal is facing challenges that stem from a decrease in overall investment and shifting priorities. Despite the evident role of…

Our broad, global portfolio includes products that help treat the top 10 leading causes of death globally, as determined by the WHO

We are committed to finding a balanced approach that considers both the imperative of enabling better health outcomes and the need for ensuring the sustainability of…

We actively sought out synergies in the diagnostic business and view partnerships as a means to avoid reinventing the wheel  

[Our] practical experiences can be immensely valuable for global south countries struggling to provide similar services

My vision for the presidency is centered on instilling pride within hospital pharmacists, encouraging a sense of accomplishment in their crucial role

Indian firms are supplying quality generic medicines which conform to global standards, and which bring down the high costs of medicines across the world. These high…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here